Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2018

01-10-2018 | Original Article

Chronic leg ulcer is a strong predictor to determine the major cardiovascular events in diabetic patients with peripheral arterial disease in Thailand

Authors: Rungrujee Kaweewan, Saritphat Orrapin, Natapong Kosachunhanun, Kiran Sony, Nimit Inpankaew, Kittipan Rerkasem

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2018

Login to get access

Abstract

Peripheral arterial disease (PAD) in patients with diabetic mellitus (DM) is a fatal condition. The most common causes of morbidity and mortality in these patients are major adverse cardiovascular events (MACE) such as myocardial infarction and death. Therefore, the study on prognostic factors of MACE in these patients is important. A multi-center, prospective cohort study of 500 DM patients with PAD, between June 2014 and July 2016, were followed up in 18 months. Primary end point was MACE, which included non-fatal myocardial infarction, stroke, worsening PAD, and death. The prognostic factors, which aggregated from recent literatures, were entered into a Cox proportional hazard model. The adequacies of treatments were evaluated by assessing the risk factor control for atherosclerosis. This project was supported by the Health System Research Institute (HSRI) Thailand. Ninety-five MACE occurred. The prognostic factors associated with MACE were chronic kidney disease (CKD) (HR 2.32, 95% CI 1.41–3.80), gangrene/chronic ulcer (HR 3.03, 95% CI 1.82–5.06), history of aortic surgery (HR 24.07, 95% CI 5.28–109.71), history of taking clopidogrel (HR 2.16, 95% CI 1.13–4.12), and history of taking warfarin (HR 3.24, 95% CI 1.50–7.02). In atherosclerosis risk factor management, patients had reached the target in the control of diastolic blood pressure (73.10%) and stopped smoking (91.83%). In summary, the prognostic factors for MACE in Thai DM patients with PAD were CKD, gangrene/chronic ulcer, history of aortic surgery, and patients with history of taking clopidogrel or warfarin. The optimization of prognostic factors and atherosclerosis risk factor should be campaigned to reduce the morbidity and mortality of these patients.
Literature
1.
go back to reference Deerochanawong C, Ferrario A. Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Glob Health. 2013;9:1–18.CrossRef Deerochanawong C, Ferrario A. Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Glob Health. 2013;9:1–18.CrossRef
3.
go back to reference Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2013;37:9.CrossRef Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2013;37:9.CrossRef
4.
go back to reference Association AD. Executive summary: Standards of medical care in diabetes—2013. Diabetes Care. 2013;36:S4–S10.CrossRef Association AD. Executive summary: Standards of medical care in diabetes—2013. Diabetes Care. 2013;36:S4–S10.CrossRef
5.
go back to reference Association AD. Standards of Medical Care in Diabetes—2017: Summary of Revisions. Diabetes Care. 2016;40:S4. Association AD. Standards of Medical Care in Diabetes—2017: Summary of Revisions. Diabetes Care. 2016;40:S4.
6.
go back to reference Rydén L, Grant PJ, Anker SD, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of diabetes (EASD). Eur Heart J. 2013;34(39):3035–87. https://doi.org/10.1093/eurheartj/eht108.CrossRefPubMed Rydén L, Grant PJ, Anker SD, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of diabetes (EASD). Eur Heart J. 2013;34(39):3035–87. https://​doi.​org/​10.​1093/​eurheartj/​eht108.CrossRefPubMed
7.
go back to reference Dosluoglu HH. Chapter 108: lower extremity arterial disease: general considerations. In: Cronenwett JL, Johnston KW, editors. Rutherford’s vascular surgery. 8th ed. Philadelphia: Elsevier; 2014. Dosluoglu HH. Chapter 108: lower extremity arterial disease: general considerations. In: Cronenwett JL, Johnston KW, editors. Rutherford’s vascular surgery. 8th ed. Philadelphia: Elsevier; 2014.
8.
go back to reference Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851–906. https://doi.org/10.1093/eurheartj/ehr211.CrossRefPubMed Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851–906. https://​doi.​org/​10.​1093/​eurheartj/​ehr211.CrossRefPubMed
9.
go back to reference Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;69:1465–508.CrossRef Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;69:1465–508.CrossRef
10.
go back to reference Nayor MG, Beckman JA. In: Cronenwett JL, Johnston KW, editors. Chapter 28: atherosclerotic risk factors: diabetes. 8th ed. Philadelphia: Elsevier; 2014. Nayor MG, Beckman JA. In: Cronenwett JL, Johnston KW, editors. Chapter 28: atherosclerotic risk factors: diabetes. 8th ed. Philadelphia: Elsevier; 2014.
11.
go back to reference Owens CD. In: Cronenwett JL, Johnston KW, editors. Chapter 5: atherosclerosis. 8th ed. Philadelphia: Elsevier; 2014. Owens CD. In: Cronenwett JL, Johnston KW, editors. Chapter 5: atherosclerosis. 8th ed. Philadelphia: Elsevier; 2014.
12.
go back to reference Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;45(Suppl S):S5–S75. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;45(Suppl S):S5–S75.
15.
go back to reference Rooke TW, Hirsch AT, Misra S, et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:2020–45.CrossRef Rooke TW, Hirsch AT, Misra S, et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:2020–45.CrossRef
16.
go back to reference Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 Pt 2):S1–S296.PubMed Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 Pt 2):S1–S296.PubMed
19.
go back to reference Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009;50:1462–73.e1–3.PubMed Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009;50:1462–73.e1–3.PubMed
20.
22.
go back to reference Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239–312. https://doi.org/10.1016/j.jacc.2005.10.009.CrossRefPubMed Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47(6):1239–312. https://​doi.​org/​10.​1016/​j.​jacc.​2005.​10.​009.CrossRefPubMed
24.
go back to reference Silvestro A, Diehm N, Savolainen H, et al. Falsely high ankle-brachial index predicts major amputation in critical limb ischemia. Vasc Med. 2006;11:69–74.CrossRef Silvestro A, Diehm N, Savolainen H, et al. Falsely high ankle-brachial index predicts major amputation in critical limb ischemia. Vasc Med. 2006;11:69–74.CrossRef
25.
go back to reference Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg. 41:110–6 Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg. 41:110–6
26.
go back to reference Orrapin S, Reanpang T, Orrapin S, Arwon S, Kattipathanapong T, Lekwanavijit S, et al. Case series of HIV infection-associated arteriopathy: diagnosis, management, and outcome over a 5-year period at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University. Int J Low Extrem Wounds. 2015;14(3):251–61. https://doi.org/10.1177/1534734615598226.CrossRefPubMed Orrapin S, Reanpang T, Orrapin S, Arwon S, Kattipathanapong T, Lekwanavijit S, et al. Case series of HIV infection-associated arteriopathy: diagnosis, management, and outcome over a 5-year period at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University. Int J Low Extrem Wounds. 2015;14(3):251–61. https://​doi.​org/​10.​1177/​1534734615598226​.CrossRefPubMed
30.
go back to reference Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, et al. One-year costs associated with cardiovascular disease in Canada: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. 2010;26(8):297–305.CrossRef Smolderen KG, Bell A, Lei Y, Cohen EA, Steg PG, Bhatt DL, et al. One-year costs associated with cardiovascular disease in Canada: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. 2010;26(8):297–305.CrossRef
33.
go back to reference Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68(10):1082–115. https://doi.org/10.1016/j.jacc.2016.03.513.CrossRefPubMed Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;68(10):1082–115. https://​doi.​org/​10.​1016/​j.​jacc.​2016.​03.​513.CrossRefPubMed
Metadata
Title
Chronic leg ulcer is a strong predictor to determine the major cardiovascular events in diabetic patients with peripheral arterial disease in Thailand
Authors
Rungrujee Kaweewan
Saritphat Orrapin
Natapong Kosachunhanun
Kiran Sony
Nimit Inpankaew
Kittipan Rerkasem
Publication date
01-10-2018
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2018
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-017-0593-y

Other articles of this Issue 4/2018

International Journal of Diabetes in Developing Countries 4/2018 Go to the issue